The vaccine developed by Russia is adenovirus-based viral vector vaccine, which is a common cold virus. The vaccine makes use of weakened particles of the novel coronavirus (the spike protein) to kickstart the body’s immune system response against the infectious contagion. According to Alexander Gintsburg, director of the Gamaleya National Research Centre “the coronavirus particles in the vaccine cannot harm the body as they cannot multiply.”
The jab will be given in two doses to stimulate an immune system response against the novel coronavirus. According to media reports, Russia is planning mass-immunization in the month of October, after inoculating medical personals and teachers.
It was just 11-08-2020 that the world’sfirst vaccine registeredby Russian authorities, and now the World Health Organisation has said it is in talks with Russia’s health ministry for a thorough review of the safety and efficacy of the vaccine, called Sputnik V.
While there was no timeline given to how long this review process might take, in under 24 hours, the health minister Mikhail Murashko has announced that mass production of the vaccines has already begun.
According to a report by Sputnik News, the first batch of the Sputnik V vaccine will be produced in two weeks time, and delivered to Russian hospitals. Mass production has reportedly begun at the factory of Russian pharma company AFK Sistema’s Binnopharm. A total of 500 million doses are expected to be made in the first 12 months of the production process.
Alexander Gintsburg, director of the Gamaleya Institute said, “Russia plans to be able to produce 5 million doses a month by December-January.”
Earlier, Industry and Trade Minister Denis Manturov had said in an interview with TASS said that the Gamaleya Institute is working with three Russian companies – Generium, R-Pharm and Binnopharm – who have facilities in the Vladimir, Yaroslavl and Moscow regions. He also said production was to start in September with ‘several thousands of doses’ being produced each month in 2020 and ‘several million’ doses by 2021.
Murashko also said, “today, quality control tests are underway. Within two weeks, the first batch of the drug will be released and will be delivered for [vaccination of] medics in health risk groups”.
Copyright Notice #
Please feel free to leave me a notice if you find this upload inappropriate.
Contact me personally if you are against an upload which
You may have rights the image or music, instead of contacting YouTube about a Copyright infringement…………
